What changed today in Regulatory: 1 safety alert, 1 recall record
Every new official record on the Pharmacy, Compounding & Regulatory Intelligence desk since this morning, each linked to its primary source.
The signal
NPHLA tracked 2 new official records on this desk today: 1 safety alert, 1 recall record.
Why this matters
Federal Register documents and FDA notices can change compliance obligations, deadlines and enforcement priorities for pharmacies, compounders and prescribers.
What changed
- Game Changer Products LLC Issues Voluntary Nationwide Recall of 10 Day Forecast Capsules Due to the Presence of Undeclared Sildenafil and Acetaminophen[1]
- Recall: Eros Apothecary Issues Recall of Candy Power For Man Organic Honey Due to Undeclared Tadalafil — reason given: not stated (firm: not stated).[2]
- Also reported by Pharmacy Times: “Earlier PRRT in Neuroendocrine Tumors: Treatment Selection and the Pharmacist’s Role”.[3]
- Also reported by Pharmacy Times: “Changing NSCLC Immunotherapy Practice: Data, Formulations, Payers, and Operations”.[4]
Who this affects
- Pharmacies
- 503A compounders
- 503B outsourcing facilities
- Pharmacists
- Prescribers
- Practice owners & operators
Jurisdictions: Florida, California.
What to watch next
No new verified deadlines in today’s records. See Deadline Watch for upcoming dates.
NPHLA takeaway
These are factual summaries of official records with no interpretation. Open the primary documents for full details; NPHLA editors add analysis where developments warrant it.
Source file
- [1]
- [2]
- [3]
- [4]
Compiled automatically from primary official sources and peer-reviewed literature. Each line is a factual summary of a public record, linked to it — no interpretation is added. NPHLA links to sources and does not republish their text. Professional information only — not medical, legal or regulatory advice for any individual situation. Our standards.